PL2015767T3 - Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego - Google Patents

Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego

Info

Publication number
PL2015767T3
PL2015767T3 PL07748079T PL07748079T PL2015767T3 PL 2015767 T3 PL2015767 T3 PL 2015767T3 PL 07748079 T PL07748079 T PL 07748079T PL 07748079 T PL07748079 T PL 07748079T PL 2015767 T3 PL2015767 T3 PL 2015767T3
Authority
PL
Poland
Prior art keywords
antisecretory factor
intraocular hypertension
treating intraocular
treating
hypertension
Prior art date
Application number
PL07748079T
Other languages
English (en)
Polish (pl)
Inventor
Hans-Arne Hansson
Stefan Lange
Eva Jennische
Original Assignee
Lantmaennen As Faktor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab
Publication of PL2015767T3 publication Critical patent/PL2015767T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL07748079T 2006-04-27 2007-04-27 Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego PL2015767T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600932 2006-04-27
EP07748079.6A EP2015767B1 (en) 2006-04-27 2007-04-27 Use of antisecretory factor for treating intraocular hypertension
PCT/SE2007/000414 WO2007126364A2 (en) 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension

Publications (1)

Publication Number Publication Date
PL2015767T3 true PL2015767T3 (pl) 2016-05-31

Family

ID=38561776

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07748079T PL2015767T3 (pl) 2006-04-27 2007-04-27 Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
PL12157100T PL2468292T3 (pl) 2006-04-27 2007-04-27 Nowe peptydy wykazujące działanie przeciwwydzielnicze

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12157100T PL2468292T3 (pl) 2006-04-27 2007-04-27 Nowe peptydy wykazujące działanie przeciwwydzielnicze

Country Status (18)

Country Link
US (2) US8207296B2 (cg-RX-API-DMAC10.html)
EP (2) EP2015767B1 (cg-RX-API-DMAC10.html)
JP (2) JP5284948B2 (cg-RX-API-DMAC10.html)
KR (1) KR20090040404A (cg-RX-API-DMAC10.html)
CN (2) CN101432013B (cg-RX-API-DMAC10.html)
AU (1) AU2007244004B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0710959B8 (cg-RX-API-DMAC10.html)
CA (2) CA2771087C (cg-RX-API-DMAC10.html)
DK (2) DK2015767T3 (cg-RX-API-DMAC10.html)
ES (2) ES2773945T3 (cg-RX-API-DMAC10.html)
IL (1) IL194773A (cg-RX-API-DMAC10.html)
MX (1) MX2008013769A (cg-RX-API-DMAC10.html)
NZ (2) NZ598426A (cg-RX-API-DMAC10.html)
PL (2) PL2015767T3 (cg-RX-API-DMAC10.html)
RU (1) RU2458703C2 (cg-RX-API-DMAC10.html)
SG (1) SG171602A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007126364A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200809115B (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
JP5820277B2 (ja) 2009-02-11 2015-11-24 ラントメネン・アーエス−ファクトール・アーベー 細胞取込を最適化するための抗分泌性因子（ａｆ）の使用
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
NZ708860A (en) * 2012-12-20 2016-09-30 Lantmännen As Faktor Ab Use of antisecretory factor (af) in glioblastoma treatment
WO2017009004A1 (en) 2015-07-10 2017-01-19 Lantmännen As-Faktor Ab Process for producing egg yolk with high content of af-16
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
WO2020002464A1 (en) 2018-06-28 2020-01-02 Lantmännen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
CN112770643A (zh) 2018-09-28 2021-05-07 兰特门内保健食品公司 包含麦芽化脱壳燕麦的可消耗产品
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
EP4125984A1 (en) 2020-03-26 2023-02-08 Lantmännen Functional Foods AB A consumable product comprising malted cereals for promoting recovery at physical activity
US20240148709A1 (en) * 2022-11-08 2024-05-09 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders
WO2026099453A1 (en) 2024-11-07 2026-05-15 Lantmännen Medical Ab Af-16 or af-17 for acute treatment of brain oedema in patients with traumatic brain injury

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
WO1997027296A1 (en) * 1996-01-26 1997-07-31 Hsc Research And Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
SE9604251L (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
AU5627000A (en) * 1999-06-21 2001-02-05 Inkine Pharmaceutical Company, Inc. Angiocidin: a CYS-SER-VAL-THR-CYS-GLY specific tumor cell adhesion receptor
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
KR20090037992A (ko) * 2006-04-27 2009-04-17 란트만넨 아스-팍토르 아베 항분비 단백질의 추가적 의학 용도
PL2040734T3 (pl) * 2006-04-27 2012-04-30 Lantmaennen As Faktor Ab Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału

Also Published As

Publication number Publication date
US20120283191A1 (en) 2012-11-08
WO2007126364A3 (en) 2008-03-06
DK2468292T3 (da) 2020-03-23
BRPI0710959B1 (pt) 2018-11-06
IL194773A0 (en) 2011-08-01
JP5284948B2 (ja) 2013-09-11
CA2650344C (en) 2017-10-31
RU2008146733A (ru) 2010-06-10
CA2771087A1 (en) 2007-11-08
KR20090040404A (ko) 2009-04-24
EP2468292A1 (en) 2012-06-27
MX2008013769A (es) 2009-02-03
PL2468292T3 (pl) 2020-08-24
BRPI0710959B8 (pt) 2021-05-25
CN102633863B (zh) 2014-08-06
IL194773A (en) 2015-07-30
CA2771087C (en) 2016-03-15
US8207296B2 (en) 2012-06-26
US9000125B2 (en) 2015-04-07
BRPI0710959A2 (pt) 2012-02-28
EP2468292B1 (en) 2019-12-18
CN102633863A (zh) 2012-08-15
US20090162296A1 (en) 2009-06-25
AU2007244004B2 (en) 2012-02-09
SG171602A1 (en) 2011-06-29
CN101432013B (zh) 2015-01-07
EP2468292B8 (en) 2020-02-26
WO2007126364A2 (en) 2007-11-08
NZ572255A (en) 2012-03-30
AU2007244004A1 (en) 2007-11-08
WO2007126364A8 (en) 2009-07-23
EP2015767A2 (en) 2009-01-21
JP2012153695A (ja) 2012-08-16
ES2561945T3 (es) 2016-03-01
ES2773945T3 (es) 2020-07-15
DK2015767T3 (en) 2016-02-08
NZ598426A (en) 2012-08-31
EP2015767B1 (en) 2016-01-06
ZA200809115B (en) 2009-07-29
RU2458703C2 (ru) 2012-08-20
JP2009535329A (ja) 2009-10-01
CA2650344A1 (en) 2007-11-08
CN101432013A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
ZA200809115B (en) Use of antisecretory factors for treating intraocular hypertension
ES2947257T5 (en) Means for controlling the progression of myopia
IL198774A0 (en) Quinazolines for pdk1 inhibition
ZA200808307B (en) Quinazolines for PDK1 inhibition
HUS1600027I1 (hu) Kompozíció pulmonáris hipertensio kezeléséhez
IL193451A0 (en) Surgical devices for treating pelvic conditions
EP2051725A4 (en) METHOD FOR THE TREATMENT OF GRAIN WITH SATURATION FACTORS
EP1993539A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
ZA200903533B (en) Process for the preparation of rosuvastatin
GB2446944B (en) Removal of prosthesis
IL198005A0 (en) Ccr2 antagonists for treatment of fibrosis
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
PL1903019T3 (pl) Sposób wytwarzania izoolefin
EP1993535A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
GB0624977D0 (en) Artificial candle
EP2013404A4 (en) OPERATING PROCESS FOR DRYERS
IL198941A0 (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
EP1993536A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
EP1993537A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
GB0609402D0 (en) Prosthesis
EP1996191A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
EP2003971A4 (en) RNAI-mediated inhibition of status in association with the histamine receptor H1
ZA200807615B (en) Renin inhibitors for the treatment of hypertension
EP1993538A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
GB0820885D0 (en) A composition for the treatment of hypertension